Lack of strong immune selection pressure by the immunodominant, HLA-A* 0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus …

C Brander, KE Hartman, AK Trocha… - The Journal of …, 1998 - Am Soc Clin Investig
C Brander, KE Hartman, AK Trocha, NG Jones, RP Johnson, B Korber, P Wentworth…
The Journal of clinical investigation, 1998Am Soc Clin Investig
Despite detailed analysis of the HIV-1-specific cytotoxic T lymphocyte response by various
groups, its relation to viral load and viral sequence variation remains controversial. We
analyzed HLA-A* 0201 restricted cytotoxic T lymphocyte responses in 17 HIV-1-infected
individuals with viral loads ranging from< 400 to 221,000 HIV RNA molecules per milliliter of
plasma. In 13 out of 17 infected subjects, CTL responses against the SLYNTVATL epitope
(p17 Gag; aa 77-85) were detectable, whereas two other HLA-A* 0201 restricted epitopes …
Despite detailed analysis of the HIV-1-specific cytotoxic T lymphocyte response by various groups, its relation to viral load and viral sequence variation remains controversial. We analyzed HLA-A*0201 restricted cytotoxic T lymphocyte responses in 17 HIV-1-infected individuals with viral loads ranging from < 400 to 221,000 HIV RNA molecules per milliliter of plasma. In 13 out of 17 infected subjects, CTL responses against the SLYNTVATL epitope (p17 Gag; aa 77-85) were detectable, whereas two other HLA-A*0201 restricted epitopes (ILKEPVHGV, IV9; and VIYQYMDDL, VL9) were only recognized by six and five individuals out of 17 individuals tested, respectively. Naturally occurring variants of the SL9 epitope were tested for binding to HLA-A*0201 and for recognition by specific T cell clones generated from five individuals. Although these variants were widely recognized, they differed by up to 10,000-fold in terms of variant peptide concentrations required for lysis of target cells. A comparison of viral sequences derived from 10 HLA-A*0201-positive individuals to sequences obtained from 11 HLA-A*0201-negative individuals demonstrated only weak evidence for immune selective pressure and thus question the in vivo efficacy of immunodominant CTL responses present during chronic HIV-1 infection.
The Journal of Clinical Investigation